Cerebain BiotechDevelopment-stage medical device company Cerebain Biotech said today that it’s planning to begin development of a medical device designed to treat Alzheimer’s disease and dementia.
The minimally invasive implantable device is designed for omentum stimulation, which the company said has a “clinically observable, positive impact” on cognitive function related to dementia and Alzheimer’s disease.
The device can be adjusted non-invasively to account for a “range of factors” including frequency, strength of stimulation and location, according to the company’s website.
